ArticleCancers2022

Administering Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer 1-6 Days Compared to More Than 14 Days after the Start of LHRH Agonist Is Associated with Better Clinical Outcomes Due to Androgen Flare.

Nicola J Nasser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.